Viral vector characterisation comprehensively assesses manufacturing viral vehicles for gene therapy. Infectivity titre quantitates functional viral particles. Particle-to-infectivity ratio indicates manufacturing efficiency. Genetic stability assessment confirms insert integrity. Purity assessment detects host cell contaminants.
Regulatory submissions include extensive characterisation. Quality control monitoring verifies consistency. Manufacturing modifications require re-characterisation. Post-approval surveillance confirms stability. Emerging assays improve characterisation capability.
Cell & Gene Therapy
Viral Vector Characterisation
Viral vector characterisation confirms the identity, potency, purity, genome integrity and biological performance of viral vectors used in advanced therapies.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →